Inventor · disambiguated record
Indravadan Ambalal Modi
Also filed as: MODI INDRAVADAN A · MODI INDRAVADAN AMBALAL
12 granted patents·11 pending applications·12 citations·filing 2002–2019
85Inventor score
Files withKHAMAR BAKULESH MAFATLAL10CADILA PHARMACEUTICALS LTD7MODI INDRAVADAN AMBALAL4CADILA PHAMACEUTICALS LTD1KHAMAR BAKULESH M1
Top patents by PatentIndex Score
23 records- 0181US10335472B2Therapeutic cancer vaccineCADILA PHARMACEUTICALS LTD·Filed 2017·Granted Jul 2, 2019·2 cites·7 claims
- 0277US8048434B2Vaccine adjuvantsCADILA PHARMACEUTICALS LTD·Filed 2006·Granted Nov 1, 2011·3 cites·22 claims
- 0373US8647643B2Farnesoid-X-receptor antagonist as a vaccine adjuvantKHAMAR BAKULESH MAFATLAL·Filed 2009·Granted Feb 11, 2014·1 cites·5 claims
- 0472US8277778B2Vaccine adjuvantsKHAMAR BAKULESH MAFATLAL·Filed 2011·Granted Oct 2, 2012·2 cites·15 claims
- 0567US11219674B2Therapeutic cancer vaccineCADILA PHARMACEUTICALS LTD·Filed 2019·Granted Jan 11, 2022·0 cites·6 claims
- 0666US9345683B2Pharmaceutical composition of taxoidsKHAMAR BAKULESH MAFATLAL·Filed 2011·Granted May 24, 2016·2 cites·9 claims
- 0758US9789187B2Stable pharmaceutical composition for atherosclerosisKHAMAR BAKULESH MAFATLAL·Filed 2010·Granted Oct 17, 2017·1 cites·11 claims
- 0858US9474727B2Pharmaceutical compositions of curcuminKHAMAR BAKULESH MAFATLAL·Filed 2011·Granted Oct 25, 2016·1 cites·12 claims
- 0955US2011020440A1Stable solutions of sparingly soluble activesCADILA PHARMACEUTICALS LTD·Filed 2008·Application pending·0 cites
- 1055US2013330375A1Therapeutic Cancer VaccineKHAMAR BAKULESH MAFATLAL·Filed 2012·Application pending·0 cites
- 1153US8110204B2Method of treating human-immunodeficiency virus (HIV) disease infectionKHAMAR BAKULESH MAFATLAL·Filed 2002·Granted Feb 7, 2012·0 cites·29 claims
- 1250US8333978B2Poly TLR antagonistMODI INDRAVADAN AMBALAL·Filed 2007·Granted Dec 18, 2012·0 cites·7 claims
- 1349US2010113802A1Process for preparing amorphous atorvastatin hemi calcium salt and its itermediateCADILA PHARMACEUTICALS LTD·Filed 2007·Application pending·0 cites
- 1449US2010104536A1P38 inhibitorsMODI INDRAVADAN AMBALAL·Filed 2008·Application pending·0 cites
- 1548US2008091022A1Preparation for methscopolamine tannateCADILA PHAMACEUTICALS LTD·Filed 2007·Application pending·0 cites
- 1647US9415078B2Method of treating desmocollin-3 expressing cancer with Mycobacterium wCADILA PHARMACEUTICALS LTD·Filed 2015·Granted Aug 16, 2016·0 cites·7 claims
- 1747US2009137633A1Stable pharmaceutical composition of rabeprazoleKHAMAR BAKULESH MAFATLAL·Filed 2004·Application pending·0 cites
- 1846US2013295648A1Pharmaceutical composition for treating cancerKHAMAR BAKULESH MAFATLAL·Filed 2012·Application pending·0 cites
- 1941US2012328574A1P38 inhibitorsMODI INDRAVADAN AMBALAL·Filed 2012·Application pending·0 cites
- 2040US2009177008A1Novel process for synthesis of itopride and its novel intermediate n-(4-hydroxybenzyl)- 3,4-dimethoxybenzamideCADILA PHARMACEUTICALS LTD·Filed 2006·Application pending·0 cites
- 2136US2007249839A1Process for the Preparation of Losartan Potassium Form IKHAMAR BAKULESH M·Filed 2006·Application pending·0 cites
- 2235US2013137852A1Novel compounds as dpp-iv inhibitors and process for preparation thereofKHAMAR BAKULESH MAFATLAL·Filed 2011·Application pending·0 cites
- 2334US9714275B2Cancer antigenMODI INDRAVADAN AMBALAL·Filed 2012·Granted Jul 25, 2017·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Indravadan Ambalal Modi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →